| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 06/28/2006 | EP1544201B1 Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications |
| 06/28/2006 | EP1434776B1 Thiazolyl substituted aminopyrimidines as plant protection agents |
| 06/28/2006 | CN1795193A N-acyl nitrogen heterocyles as ligands of peroxisome proliferator-activated receptors |
| 06/28/2006 | CN1795188A Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 06/28/2006 | CN1795177A 1,2,4-substituerte 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity |
| 06/28/2006 | CN1794990A Di-aryl substituted pyrrole modulators of metabotropic glutamate receptor-5 |
| 06/28/2006 | CN1261430C Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
| 06/28/2006 | CN1261429C Cholesterol lowering benzo [b] thiophenes and benzo[d] isothiazoles |
| 06/28/2006 | CN1261420C Process for the manufacture of thiazole derivatives with pesticide activity |
| 06/28/2006 | CN1261099C Tetrahydroquinoline derivatives |
| 06/27/2006 | US7067679 Therapy for breast cancer; plant extracts |
| 06/27/2006 | US7067665 phenylethoxy-phenyl- or -pyridyl- (acet) amides, N-substituted with pyrimidine ring-containing (tetrahydro)pyridines or phenyl groups; e.g., 3-[2-(2,4-Dichloro-phenyl)-ethoxy]-4-methoxy-N-[4-(pyrimidin-2-ylsulfamoyl)-phenyl]-benzamide; treating cardiovascular disorders such as thromboses and restenoses |
| 06/27/2006 | US7067655 Adenosine A2a receptor antagonists |
| 06/27/2006 | US7067544 a high purity epothilone from Sorangium cellulosum; anticarcinogenic, antitumor agents |
| 06/27/2006 | US7067537 Anticancer, antitumor agents |
| 06/27/2006 | US7067534 Melanin-concentrating hormone; N-(N'-substituted indolyl)methyl-4-(m-alkylamidophenyl) piperidine; antidepressants, anxiolytic agents; obesity, incontinence |
| 06/27/2006 | US7067533 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 06/27/2006 | US7067532 Substituted quinolines as antitumor agents |
| 06/27/2006 | US7067531 Quinolinone derivatives containing imidazole rings is useful as anticarcinogenic agent |
| 06/27/2006 | US7067529 a 1-benzoyl-6- or 7-methoxy-isoquinoline; antidiabetic agents; Type II diabetes |
| 06/27/2006 | US7067525 Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | US7067516 Compounds used as antiinflammatory agents and enzyme inhibitors |
| 06/27/2006 | US7067513 Phenylpiperazines |
| 06/27/2006 | US7067286 Cystobacterineae host cells containing heterologous PKS genes for the synthesis of polykedtides |
| 06/22/2006 | WO2006066197A1 Tetrahydroisoquinoline compounds for treatment of cns disorders |
| 06/22/2006 | WO2006066173A2 Novel mch receptor antagonists |
| 06/22/2006 | WO2006065946A1 Pyrid-2-ones useful as inhibitors of tec family protein kinases for the treatment of inflammatory, proliferative and immunologically-mediated diseases |
| 06/22/2006 | WO2006065942A2 Thiazolium compounds and uses thereof |
| 06/22/2006 | WO2006065686A2 Spiro derivatives as lipoxygenase inhibitors |
| 06/22/2006 | WO2006065646A1 Benzisothiazole-1, 1-dioxide acting as antagonists to the vanilloid receptor subtype 1 (vr1) and uses thereof |
| 06/22/2006 | WO2006065480A2 Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control |
| 06/22/2006 | WO2006065277A2 Heterocyclic aspartyl protease inhibitors |
| 06/22/2006 | WO2006064906A1 Amorphous composition |
| 06/22/2006 | WO2006064298A1 Process for preparation of high-purity meloxicam and meloxicam potassium salt |
| 06/22/2006 | WO2006064286A1 Cathepsin s inhibitors |
| 06/22/2006 | WO2006063863A1 Biaromatic compounds that modulate ppar type receptors, process for preparing them and use thereof in cosmetic or pharmaceutical compositions |
| 06/22/2006 | WO2006063806A1 Meta-substituted thiazolidinones, the production thereof and their use as medicaments |
| 06/22/2006 | WO2006013049A3 Benzyloxy derivatives as maob inhibitors |
| 06/22/2006 | WO2003061655A8 2-aminothiazole allosteric enhancers of a1 adenosine receptors |
| 06/22/2006 | US20060135769 Farnesyl transferase inhibiting 4-heterocyclyl-quinoline and quinazoline derivatives |
| 06/22/2006 | US20060135763 delta-opioid receptor agonists as analgesics having reduced side effects and antagonists as immunosuppressants, antiinflammatory agents, neurological, psychiatric , urological and reproductive conditions; e.g. 10-(8-Methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-10H-phenoxazine-3-carboxylic acid diethylamide |
| 06/22/2006 | US20060135593 N-acyl nitrogen heterocyles as ligands of peroxisome proliferator-activated receptors |
| 06/22/2006 | US20060135589 1h-Indazole-3-carboxamide compounds as cyclin dependent kinase (cdk) inhibitors |
| 06/22/2006 | US20060135576 2-Amino-(imidazole, thiazole, or oxazole) derivatives; tyrosine kinase, endothelial growth factor, angiogenesis and fibroblast growth factor inhibitors; anticarcinogenic and antidiabetic agents |
| 06/22/2006 | US20060135575 2-Acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof |
| 06/22/2006 | US20060135573 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 06/22/2006 | US20060135570 Cyclic sulfamides for inhibiton of gamma-secretase |
| 06/22/2006 | US20060135566 E.g., N-[5-(2-Benzoylamino-4-pyridyl)-4-(3,5-dimethylphenyl)-1,3-thiazol-2-yl]acetamide,; the compounds have adenosine A3 receptor antagonistic activity, a p38 MAP kinase inhibitory action, and a TNF- alpha production-inhibitory action |
| 06/22/2006 | US20060135559 Novel imidazoline compounds |
| 06/22/2006 | US20060135557 neurodegenerative diseases such as Alzheimer's disease, apoplexy and brain ischemic injuries |
| 06/22/2006 | US20060135554 Novel compounds |
| 06/22/2006 | US20060135543 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 06/22/2006 | US20060135532 Anticoagulants; antithrombotic agents in the treatment and prevention of thrombosis |
| 06/22/2006 | US20060135530 Such as (2E)-3-[3-(aminomethyl)-2-isobutyl-4-(4-methylphenyl)quinolin-6-yl]acrylamide; dipeptidyl peptidase IV inhibitors; diabetes, obesity, glucose intolerance |
| 06/22/2006 | US20060135519 5-aryltetrazole compounds and compositions thereof |
| 06/22/2006 | US20060135504 N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines |
| 06/22/2006 | US20060135501 Piperidinyl-thiazole carboxylic acid derivatives as angiogenesis inhibitors |
| 06/22/2006 | US20060135474 Methods for the preparation, isolation and purification of epothilone B, and X-ray crystal structures of epothilone B |
| 06/22/2006 | US20060134001 Conjugated infrared fluorescent substances for detection of cell death |
| 06/22/2006 | DE102004060984A1 New 4-heterocyclyl-benzamide derivatives, useful as antithrombotic agents for treating or preventing e.g. deep vein thrombosis or reocclusion after angioplasty, are inhibitors of factor Xa and other serine proteases |
| 06/22/2006 | CA2592353A1 Tetrahydroisoquinoline compounds for treatment of cns disorders |
| 06/22/2006 | CA2591413A1 Pyrid-2-ones useful as inhibitors of tec family protein kinases for the treatment of inflammatory, proliferative and immunologically-mediated diseases |
| 06/22/2006 | CA2591069A1 Benzisothiazole-1, 1-dioxide acting as antagonists to the vanilloid receptor subtype 1 (vr1) and uses thereof |
| 06/22/2006 | CA2590396A1 Meta-substituted thiazolidinones, their production and use as pharmaceutical agents |
| 06/22/2006 | CA2589678A1 Novel mch receptor antagonists |
| 06/22/2006 | CA2589527A1 Pyridazinone compounds |
| 06/22/2006 | CA2589363A1 Spiro derivatives as lipoxygenase inhibitors |
| 06/22/2006 | CA2588384A1 Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control |
| 06/21/2006 | EP1671969A2 Thiazolyl inhibitors of tec family tyrosine kinases |
| 06/21/2006 | EP1670794A2 Vanilloid receptor ligands and their use in treatments |
| 06/21/2006 | EP1670791A2 Thiophene-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 06/21/2006 | EP1670790A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 06/21/2006 | EP1670784A1 Heteroaryl-substituted imdazole derivatives as glutamate receptor antagonists |
| 06/21/2006 | EP1670783A2 Antithrombotic aromatic ethers |
| 06/21/2006 | EP1670773A1 Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof |
| 06/21/2006 | EP1670757A1 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
| 06/21/2006 | EP1670478A2 Heteroaromatic selective inhibitors of neuronal nitric oxide synthase |
| 06/21/2006 | EP1670474A2 Cyclic pyrazinoylguanidine sodium channel blockers |
| 06/21/2006 | EP1670473A1 Substituted quinolines as protein tyrosine kinase enzyme inhibitors |
| 06/21/2006 | EP1450797B1 Benzothiazole derivatives |
| 06/21/2006 | EP1286985B1 Substituted pyridine herbicides |
| 06/21/2006 | EP1268419B1 Pyrrolidine derivatives useful as bax inhibitors |
| 06/21/2006 | EP1255734B1 Isatine derivatives with neurotrophic activity |
| 06/21/2006 | EP1208092B1 Sulfonamide derivative as a matrix metalloproteinase inhibitor |
| 06/21/2006 | EP0815100B1 Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 06/21/2006 | CN1791600A Benzothiazole derivatives as adenosine receptor ligands |
| 06/21/2006 | CN1791599A 丙型肝炎抑制剂化合物 Hepatitis C inhibitor compounds |
| 06/21/2006 | CN1791598A Benzimidazole-derivatives as factor Xa inhibitors |
| 06/21/2006 | CN1791596A Anti-cancer medicaments |
| 06/21/2006 | CN1791591A Bioreductively-activated prodrugs |
| 06/21/2006 | CN1791584A Process for preparing a 4,7-bis(5-halothien-2-yl)-2,1,3-benzothiadiazole and a precursor therefor |
| 06/21/2006 | CN1791581A Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors |
| 06/21/2006 | CN1791578A Diarylmethylidene piperidine derivatives and their use as delta opioid receptor agonists |
| 06/21/2006 | CN1791576A Benzamide modulators of metabotropic glutamate receptors |
| 06/21/2006 | CN1791575A Cyanofluoropyrrolidine derivative. |
| 06/21/2006 | CN1791572A Novel compounds |
| 06/21/2006 | CN1791410A Methods for treating or preventing an inflammatory or metabolic condition by inhibiting JNK |
| 06/21/2006 | CN1791405A Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine A2a receptor |
| 06/21/2006 | CN1791402A Ophthalmic compositions for treating ocular hypertension |